Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $577,261 - $644,977
-3,420 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $572,131 - $653,220
3,420
3,420 $638,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Marietta Investment Partners LLC Portfolio

Follow Marietta Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marietta Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marietta Investment Partners LLC with notifications on news.